StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Enovis operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Enovis's operating income for the twelve months ending Jul 3, 2026 was -$1.04B. For fiscal 2025 it was -$1.12B. The highest annual figure on record is $409.55M in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.12B–
FY2024Dec 31, 2024-$775.72M–
FY2023Dec 31, 2023-$65.71M–
FY2022Dec 31, 2022-$71.18M–
FY2021Dec 31, 2021-$62.80M–
FY2020Dec 31, 2020-$66.18M-132.5%
FY2019Dec 31, 2019$203.61M+34.4%
FY2018Dec 31, 2018$151.54M+11.8%
FY2017Dec 31, 2017$135.60M-42.7%
FY2016Dec 31, 2016$236.85M-10.8%
FY2015Dec 31, 2015$265.62M-35.1%
FY2014Dec 31, 2014$409.55M+0.8%
FY2013Dec 31, 2013$406.39M+190.3%
FY2012Dec 31, 2012$140.01M+440.5%
FY2011Dec 31, 2011$25.91M-24.6%
FY2010Dec 31, 2010$34.37M-13.3%
FY2009Dec 31, 2009$39.63M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 3, 2026$17.41M–
Q1 FY2026Apr 3, 2026$6.53M–
Q4 FY2025Dec 31, 2025-$502.18M–
Q3 FY2025Oct 3, 2025-$558.49M–
Q2 FY2025Jul 4, 2025-$16.80M–
Q1 FY2025Apr 4, 2025-$46.77M–
Q4 FY2024Dec 31, 2024-$664.75M–
Q3 FY2024Sep 27, 2024-$31.74M–
Q2 FY2024Jun 28, 2024-$44.22M–
Q1 FY2024Mar 29, 2024-$35.01M–
Q4 FY2023Dec 31, 2023-$5.76M–
Q3 FY2023Sep 29, 2023-$20.49M–
Q2 FY2023Jun 30, 2023-$14.49M-361.0%
Q1 FY2023Mar 31, 2023-$24.97M–
Q4 FY2022Dec 31, 2022-$28.19M–
Q3 FY2022Sep 30, 2022-$17.92M–
Q2 FY2022Jul 1, 2022$5.55M–
Q1 FY2022Apr 1, 2022-$30.63M-150.0%
Q4 FY2021Dec 31, 2021-$18.21M–
Q3 FY2021Oct 1, 2021-$16.11M-126.0%
Q2 FY2021Jul 2, 2021-$10.35M–
Q1 FY2021Apr 2, 2021$61.31M+30.9%
Q4 FY2020Dec 31, 2020-$170.03M-285.0%
Q3 FY2020Oct 2, 2020$61.93M-8.7%
Q2 FY2020Jul 3, 2020-$4.92M-111.8%
Q1 FY2020Apr 3, 2020$46.84M+1907.6%
Q4 FY2019Dec 31, 2019$91.88M+243.3%
Q3 FY2019Sep 27, 2019$67.86M+93.6%
Q2 FY2019Jun 28, 2019$41.53M-8.6%
Q1 FY2019Mar 29, 2019$2.33M-96.2%
Q4 FY2018Dec 31, 2018$26.77M–
Q3 FY2018Sep 28, 2018$35.06M-53.1%
Q2 FY2018Jun 29, 2018$45.42M-35.2%
Q1 FY2018Mar 31, 2018$62.17M+3.2%
Q4 FY2017Dec 31, 2017-$69.51M-217.0%
Q3 FY2017Sep 29, 2017$74.77M+27.3%
Q2 FY2017Jun 30, 2017$70.12M–
Q1 FY2017Mar 31, 2017$60.22M–
Q4 FY2016Dec 31, 2016$59.43M–
Q3 FY2016Sep 30, 2016$58.71M–

More Enovis figures

See a number that looks wrong?